Not Every Thyroid Nodule Needs a Needle: Why Finding More Thyroid Cancer Hasn’t Saved More Lives

A dirt footpath forking into two trails through a bare, moss-covered autumn forest in thick morning fog, a quiet image for the decision about thyroid nodule biopsy.
  • In the United States, thyroid cancer diagnoses nearly tripled between 1975 and 2009, from 4.9 to 14.3 per 100,000 people, almost entirely from small papillary cancers, while the death rate stayed flat at about 0.5 per 100,000.
  • When thyroid ultrasound became a routine part of health checkups in South Korea, diagnoses rose 6.4-fold between 1999 and 2008, and 94 percent of the increase was tumors smaller than 2 centimeters, found mainly by screening.
  • When eight radiologists applied the American College of Radiology’s TI-RADS scoring system to the same 100 thyroid nodules, the average number they recommended for biopsy fell from 80 to 57 and their accuracy improved.

Maybe it showed up on a CT scan ordered for something else, or on a neck ultrasound that was checking your arteries. The report says “thyroid nodule,” and suddenly you are reading about thyroid cancer at midnight. Here is the part that should settle your pulse first: nodules are extraordinarily common. A pooled analysis of more than a hundred studies put their prevalence at about one in four people, and closer to 37 percent in women. Most people assume a thyroid nodule biopsy is the safe, responsible default, that if something is there you put a needle in it and find out. That instinct makes sense, and for some nodules it is exactly right. For a lot of them, though, it is the first step in a cascade that was never going to help. The uncomfortable truth thyroid specialists have been wrestling with for a decade is that looking harder for thyroid cancer has found an enormous amount of it, and almost none of that extra finding has changed how many people die from it.

The numbers are striking. In the United States, thyroid cancer diagnoses nearly tripled between 1975 and 2009, from 4.9 to 14.3 per 100,000 people, and virtually the entire increase was small papillary cancers, the slow-growing type. Over the same years the death rate did not move; it stayed at about 0.5 per 100,000. South Korea ran the experiment at full scale when thyroid ultrasound became a routine add-on to health checkups: diagnoses rose 6.4-fold in under a decade, and 94 percent of the increase was tumors smaller than 2 centimeters, found mainly by screening. When far more disease is found but the same number of people die, that is the fingerprint of overdiagnosis, real cancers under the microscope that were never going to cause harm. The US Preventive Services Task Force weighed all of this, judged the net benefit of screening people without symptoms to be negative, and recommended against it. The most reassuring data come from Japan, where 1,235 people with tiny, low-risk papillary cancers chose to be watched with ultrasound instead of having surgery. Over an average of more than six years, none developed spread to distant organs and none died of thyroid cancer. Younger patients were more likely to see some growth, which is why watching is a plan, not a shrug.

Do I need a thyroid nodule biopsy?

Finding more thyroid cancer hasn’t saved more lives, and that is why I don’t biopsy every nodule. This is one of the places in medicine where “let’s just check” can do more harm than good: a needle result can come back uncertain, uncertain results can lead to surgery, and the task force judged the harms of treating screen-found thyroid cancer to be at least moderate. What I want instead is a decision made on purpose. Radiologists now grade nodules with a system called TI-RADS, which scores the ultrasound features that predict cancer and pairs each score with a size at which a biopsy makes sense. When eight radiologists reapplied that system to the same 100 nodules, the average number they would have sent for biopsy dropped from 80 to 57, and their accuracy nearly doubled. So before you agree to a needle, ask three things: what is the TI-RADS category, how big is the nodule, and is watching with a repeat ultrasound a reasonable option for this one? Know, too, when the math changes. A lump you can feel growing, a new hoarse voice, past radiation to the neck, or thyroid cancer in a close relative deserve a prompt, careful look. Trouble swallowing deserves a look too, though it often comes from a large benign nodule. The best question about a thyroid nodule isn’t “Is it cancer?” It’s “Does this one actually need a needle?”

References

  1. Mu, C., Ming, X., Tian, Y., Liu, Y., Yao, M., Ni, Y., et al. (2022). Mapping global epidemiology of thyroid nodules among general population: A systematic review and meta-analysis. Frontiers in Oncology, 12, 1029926.
  2. Davies, L., & Welch, H. G. (2014). Current thyroid cancer trends in the United States. JAMA Otolaryngology–Head & Neck Surgery, 140(4), 317-322.
  3. Park, S., Oh, C. M., Cho, H., Lee, J. Y., Jung, K. W., Jun, J. K., et al. (2016). Association between screening and the thyroid cancer “epidemic” in South Korea: Evidence from a nationwide study. BMJ, 355, i5745.
  4. Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Barry, M. J., Davidson, K. W., Doubeni, C. A., et al. (2017). Screening for thyroid cancer: US Preventive Services Task Force recommendation statement. JAMA, 317(18), 1882-1887.
  5. Ito, Y., Miyauchi, A., Kihara, M., Higashiyama, T., Kobayashi, K., & Miya, A. (2014). Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid, 24(1), 27-34.
  6. Tessler, F. N., Middleton, W. D., Grant, E. G., Hoang, J. K., Berland, L. L., Teefey, S. A., et al. (2017). ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White paper of the ACR TI-RADS Committee. Journal of the American College of Radiology, 14(5), 587-595.
  7. Hoang, J. K., Middleton, W. D., Farjat, A. E., Langer, J. E., Reading, C. C., Teefey, S. A., et al. (2018). Reduction in thyroid nodule biopsies and improved accuracy with American College of Radiology Thyroid Imaging Reporting and Data System. Radiology, 287(1), 185-193.

Comments are closed

Christopher L. Bray, MD, PhD, CPE, FACP — board-certified in Internal and Integrative Medicine.

Archangel Michael Health is a telehealth-first Direct Primary Care practice founded by Christopher L. Bray, MD, PhD, CPE, FACP, based in Gainesville, Florida, serving patients by telehealth in Florida, Georgia, Texas, Arizona, North Carolina, Tennessee, and New Hampshire, with house calls in Alachua County, Florida.

Learn more about becoming a patient: https://archangelmichaelhealth.com/inquiries/

Latest Comments

No comments to show.